10-hydroxycamptothecin derivatives (Chiba)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Name10-hydroxycamptothecin derivatives (Chiba)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDNA topoisomerase I inhibitors

TargetsDNA topoisomerase I

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesChiba University

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChiba University

Active IndicationsN/A

Inactive IndicationsSolid tumours

ATC CodeN/A